Table 3.
Frequencies of the main CVID-associated gene alterations in the NHL and CVID populations.
| Gene symbol | Prevalence of the samples studied (somatic mutation) | CVID prevalence (germline mutation) | Gene symbol | Prevalence of the samples studied (somatic mutation) | CVID prevalence (germline mutation) |
|---|---|---|---|---|---|
| PIK3CD | 6 | 2.674 | NOD2 | 0.2 | Unknown prevalence |
| KMT2C | 5 | Unknown prevalence | PMS2 | 0.2 | Unknown prevalence |
| STAT3 | 4 | Unknown prevalence | TNFRSF13C | 0.2 | 0.10 |
| MSH2 | 3 | Unknown prevalence | SH3KBP1 | 0.2 | Unknown prevalence |
| NFKB2 | 2.4 | 0.535 | ARHGEF1 | 0.2 | Unknown prevalence |
| PTEN | 1.8 | Unknown prevalence | CD84 | 0.2 | Unknown prevalence |
| PIK3R1 | 1.3 | 0.481 | IL10RA | 0.2 | Unknown prevalence |
| LRBA | 0.9 | 2.674 | MS4A1 | 0.2 | 0.053 |
| MSH5 | 0.8 | 0.4 | NFKB1 | 0.2 | 0.16 |
| CLEC16A | 0.5 | Unknown prevalence | TNFRSF11A | 0.2 | Unknown prevalence |
| PLCG2 | 0.5 | 0.214 | TNFSF11 | 0.2 | Unknown prevalence |
| IRF2BP2 | 0.5 | 0.053 | MOGS | 0.2 | Unknown prevalence |
| RAC2 | 0.5 | 0.053 | ACOT4 | 0.1 | Unknown prevalence |
| ATP6AP1 | 0.5 | Unknown prevalence | CTLA4 | 0.1 | 0.642 |
| CR2 | 0.4 | 0.107 | FCGR2A | 0.1 | Unknown prevalence |
| TNFRSF4 | 0.4 | Unknown prevalence | OR10X1 | 0.1 | Unknown prevalence |
| DOCK8 | 0.3 | Unknown prevalence | SLC25A5 | 0.1 | Unknown prevalence |
| PRKCD | 0.3 | 0.214 | STXBP2 | 0.1 | Unknown prevalence |
| TNFRSF1A | 0.3 | Unknown prevalence | TRNT1 | 0.1 | Unknown prevalence |
| CD19 | 0.2 | 0.374 | TNFRSF13B | 0.1 | 0.07 |
| IKZF1 | 0.2 | 0.321 | TNFSF13 | 0.1 | Unknown prevalence |
| VAV1 | 0.2 | 0.053 | TNFSF12 | 0.1 | 0.053 |